BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25669765)

  • 1. SPECT radiopharmaceuticals for imaging chronic inflammatory diseases in the last decade.
    Anzola LK; Galli F; Dierckx RA
    Q J Nucl Med Mol Imaging; 2015 Jun; 59(2):197-213. PubMed ID: 25669765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of radiolabelled anti-TNFa monoclonal antibodies for diagnostic purposes and therapy evaluation.
    Glaudemans AW; Dierckx RA; Kallenberg CG; Fuentes KL
    Q J Nucl Med Mol Imaging; 2010 Dec; 54(6):639-53. PubMed ID: 21221071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New SPECT and PET Radiopharmaceuticals for Imaging Inflammatory Diseases: A Meta-analysis of the Last 10 Years.
    Pacilio M; Lauri C; Prosperi D; Petitti A; Signore A
    Semin Nucl Med; 2018 May; 48(3):261-276. PubMed ID: 29626943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting monocytes and macrophages by means of SPECT and PET.
    Van De Wiele C; Sathekge M; Maes A
    Q J Nucl Med Mol Imaging; 2014 Sep; 58(3):269-75. PubMed ID: 24844256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular imaging of rheumatoid arthritis by radiolabelled monoclonal antibodies: new imaging strategies to guide molecular therapies.
    Malviya G; Conti F; Chianelli M; Scopinaro F; Dierckx RA; Signore A
    Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):386-98. PubMed ID: 19777175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin receptor imaging by SPECT and PET in patients with chronic inflammatory disorders: a systematic review.
    Anzola LK; Glaudemans AWJM; Dierckx RAJO; Martinez FA; Moreno S; Signore A
    Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2496-2513. PubMed ID: 31463594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPECT imaging of joint inflammation with Nanobodies targeting the macrophage mannose receptor in a mouse model for rheumatoid arthritis.
    Put S; Schoonooghe S; Devoogdt N; Schurgers E; Avau A; Mitera T; D'Huyvetter M; De Baetselier P; Raes G; Lahoutte T; Matthys P
    J Nucl Med; 2013 May; 54(5):807-14. PubMed ID: 23447654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiolabelled peptides and monoclonal antibodies for therapy decision making in inflammatory diseases.
    Malviya G; Signore A; Laganà B; Dierckx RA
    Curr Pharm Des; 2008; 14(24):2401-14. PubMed ID: 18781990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular imaging with macrophage CRIg-targeting nanobodies for early and preclinical diagnosis in a mouse model of rheumatoid arthritis.
    Zheng F; Put S; Bouwens L; Lahoutte T; Matthys P; Muyldermans S; De Baetselier P; Devoogdt N; Raes G; Schoonooghe S
    J Nucl Med; 2014 May; 55(5):824-9. PubMed ID: 24686780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synovitis and bone inflammation in early rheumatoid arthritis: high-resolution multi-pinhole SPECT versus MRI.
    Buchbender C; Ostendorf B; Mattes-György K; Miese F; Wittsack HJ; Quentin M; Specker C; Schneider M; Antoch G; Müller HW; Scherer A
    Diagn Interv Radiol; 2013; 19(1):20-4. PubMed ID: 23255070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation correction of somatostatin receptor SPECT by integrated low-dose CT: is there an impact on sensitivity?
    Steffen IG; Mehl S; Heuck F; Elgeti F; Furth C; Amthauer H; Ruf J
    Clin Nucl Med; 2009 Dec; 34(12):869-73. PubMed ID: 20139819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging B lymphocytes in autoimmune inflammatory diseases.
    Iodice V; Laganà B; Lauri C; Capriotti G; Germano V; D'Amelio R; Picchianti Diamanti A
    Q J Nucl Med Mol Imaging; 2014 Sep; 58(3):258-68. PubMed ID: 25265247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-photon emission computed tomography/computed tomography in brain tumors.
    Schillaci O; Filippi L; Manni C; Santoni R
    Semin Nucl Med; 2007 Jan; 37(1):34-47. PubMed ID: 17161038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Status of Molecular Imaging in Inflammatory and Autoimmune Disorders.
    Signore A; Anzola KL; Auletta S; Varani M; Petitti A; Pacilio M; Galli F; Lauri C
    Curr Pharm Des; 2018; 24(7):743-753. PubMed ID: 29384051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor targeting agents for imaging inflammation/infection: where are we now?
    Signore A; Chianelli M; D'Alessandria C; Annovazzi A
    Q J Nucl Med Mol Imaging; 2006 Sep; 50(3):236-42. PubMed ID: 16868537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of single-photon emission computed tomography and SPECT/computed tomography in oncologic imaging.
    Brandon D; Alazraki A; Halkar RK; Alazraki NP
    Semin Oncol; 2011 Feb; 38(1):87-108. PubMed ID: 21362518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotracer Imaging of Peripheral Vascular Disease.
    Stacy MR; Zhou W; Sinusas AJ
    J Nucl Med Technol; 2015 Sep; 43(3):185-92. PubMed ID: 26338845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging of inflammatory reactions.
    Signore A
    Q J Nucl Med Mol Imaging; 2014 Sep; 58(3):235-6. PubMed ID: 25265245
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeted nuclear imaging of breast cancer: status of radiotracer development and clinical applications.
    Kong FL; Kim EE; Yang DJ
    Cancer Biother Radiopharm; 2012 Mar; 27(2):105-12. PubMed ID: 21877909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular imaging of breast cancer.
    Oude Munnink TH; Nagengast WB; Brouwers AH; Schröder CP; Hospers GA; Lub-de Hooge MN; van der Wall E; van Diest PJ; de Vries EG
    Breast; 2009 Oct; 18 Suppl 3():S66-73. PubMed ID: 19914546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.